Assertio Therapeutics to Participate in Upcoming Investor Conferences

LAKE FOREST, Ill., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. ASRT, a leading specialty pharmaceutical company committed to advancing patient care, today announced that members of senior management will participate at the following investor conferences.

Stifel 2018 Healthcare Conference

• Date:  Wednesday, Nov. 14, 2018
• Presentation Time:  2:00 p.m. EST
• Location:  New York, NY

Piper Jaffray 30^th Annual Healthcare Conference

• Dates:  Nov. 27-29, 2018
• Presentation Time:  TBD 
• Location:  New York, NY

Global Mizuho Investor Conference

• Date:  Monday, Dec. 3, 2018
• Location:  New York, NY

Conferences with presentations will webcast live and may be accessed by visiting Assertio's website at http://investor.assertiotx.com. A replay of the webcasts will be available.

About Assertio Therapeutics, Inc.

Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company's core areas of neurology, orphan and specialty medicines. Assertio currently markets three FDA-approved products and continues to identify, license and develop new products that offer enhanced options for patients that may be underserved by existing therapies. To learn more about Assertio, visit www.assertiotx.com.

Investor and Media Contact:

John B. Thomas

Senior Vice President, Investor Relations and Corporate Communications

jthomas@assertiotx.com